OBJECTIVE To elucidate the molecular mechanism and the anti-breast cancer effect of polyphyllinⅠ,which is a natural compound extracted from Rhizoma of Paris polyphyllin.METHODS Human breast cancer cells were treated ...OBJECTIVE To elucidate the molecular mechanism and the anti-breast cancer effect of polyphyllinⅠ,which is a natural compound extracted from Rhizoma of Paris polyphyllin.METHODS Human breast cancer cells were treated with polyphyllinⅠ,after which DRP1-dependent mitochondrial fission and apoptosis,mitophagy and PINK1/PARK2 pathway were evaluated.A genetic approach was employed to determine how knockdown of PINK1 with sh RNA regulates polyphyllinⅠ-induced mitophagy and apoptosis.The inhibitory effect of polyphyllinⅠon tumor growth in a breast cancer cell xenograft mouse model was also examined.RESULTS PolyphyllinⅠenhanced the stabilization of full-length PINK1at the mitochondrial surface,leading to PARK2 recruitment to mitochondria,and culminating in mitophagy.PolyphyllinⅠalso induced dephosphorylation of DRP1 at Ser637 and mitochondrial translocation of DRP1,leading to mitochondrial fission and apoptosis.Knockdown of PINK1 evidently suppressed mitophagy stimulated by polyphyllinⅠ,and markedly enhanced DRP1-dependent mitochondrial fission and apoptosis induced by polyphyl inⅠ.Furthermore,suppression of DRP1 by mdivi-1 or sh RNA inhibits PINK1 knockdown-mediated mitochondrial fragmentation and apoptosis in response to polyphyllinⅠtreatment,suggesting that depletion of PINK1 lead to mitochondrial fragmentation due to excessive fission.Our in vivo study also showed that knockdown of PINK1potentiated polyphyllinⅠ-mediated inhibition of tumor growth in a breast cancer cell xenograft mouse model.CONCLUSION Our study provides a mechanism to support the role of PINK1 in the regulation of polyphyl inⅠ-induced mitophagy and apoptosis,and suggest polyphylinⅠas a potential drug for treatment of breast cancer.展开更多
目的:研究重楼皂苷Ⅰ(PPⅠ)对去势抵抗性人前列腺癌PC3细胞生长的抑制作用及其分子机制。方法:体外培养PC3细胞,予不同浓度(0.4、0.8、1.2、1.6、2.0、2.4μmol/L)的PPⅠ处理24、48、72 h,另设对照组,MTT法观察PPⅠ对PC3细胞增殖的影响...目的:研究重楼皂苷Ⅰ(PPⅠ)对去势抵抗性人前列腺癌PC3细胞生长的抑制作用及其分子机制。方法:体外培养PC3细胞,予不同浓度(0.4、0.8、1.2、1.6、2.0、2.4μmol/L)的PPⅠ处理24、48、72 h,另设对照组,MTT法观察PPⅠ对PC3细胞增殖的影响;流式细胞术检测细胞凋亡率;Western印迹检测PPⅠ对磷酸化细胞外调节蛋白激酶1/2(p-ERK1/2)、细胞外调节蛋白激酶1/2(ERK1/2)、核转录因子kappa B(NF-κB)/p65以及DNA甲基转移酶1(DNMT1)蛋白表达的影响,并加入ERK1/2抑制剂(PD98059)后检测PPⅠ对NF-κB/p65表达的影响。结果:MTT结果显示,PPⅠ能抑制PC3细胞的体外增殖,与对照组相比,PC3细胞从给药浓度0.4μmol/L(0.85±0.05 vs 1.00±0.00,P<0.01)开始明显下降,且呈时间和剂量依赖性。流式细胞术检测显示,PPⅠ能明显诱导PC3细胞早期凋亡,与对照组相比,PC3细胞早期凋亡率从给药浓度0.8μmol/L(13.83±2.97 vs 4.83±0.95)开始明显增加(P均<0.01),且呈剂量依赖性;Western印迹显示,PPⅠ以时间依赖性上调p-ERK1/2和ERK1/2蛋白的激活与表达,与对照组相比,给药时间从2 h(1.73±0.17 vs 1.00±0.00,P<0.01)开始,p-ERK1/2明显被激活表达,PPⅠ以剂量依赖性下调NF-κB/p65、DNMT1蛋白的表达,与对照组相比,给药浓度分别从1.6μmol/L(0.67±0.11 vs 1.00,P<0.01)与1.2μmol/L(0.63±0.06 vs 1.00±0.00,P<0.01)开始,NF-κB/p65、DNMT1表达明显下调;抑制ERK1/2磷酸化能逆转重楼皂苷Ⅰ对NF-κB/p65蛋白表达的下调,与PPⅠ组相比,PD98059+PPⅠ组NF-κB/p65蛋白表达(0.86±0.18 vs 0.43±0.09,P<0.05)明显上调。结论:PPⅠ可能通过介导ERK1/2通路抑制NF-κB/p65和DNMT1蛋白表达,诱导PC3细胞早期凋亡,进而抑制细胞增殖。展开更多
OBJECTIVE:To investigate the synergistic effects of polyphyllin Ⅰ(PPⅠ)combined with tumor necrosis factorrelated apoptosis-inducing ligand(TRAIL)on the growth of osteosarcoma cells through downregulating the Wnt/β-...OBJECTIVE:To investigate the synergistic effects of polyphyllin Ⅰ(PPⅠ)combined with tumor necrosis factorrelated apoptosis-inducing ligand(TRAIL)on the growth of osteosarcoma cells through downregulating the Wnt/β-catenin signaling pathway.METHODS:Cell viability,apoptosis and cell cycle distribution were examined using cell counting kit-8 and flow cytometry assays.The morphology of cancer cells was observed with inverted phase contrast microscope.The migration and invasion abilities were examined by xCELLigence real time cell analysis DP system and transwell assays.The expressions of poly(adenosine diphosphate-ribose)polymerase,C-Myc,Cyclin B1,cyclin-dependent kinases 1,N-cadherin,Vimentin,Active-β-catenin,β-catenin,p-glycogen synthase kinase 3β(GSK-3β)and GSK-3βwere determined by Western blotting assay.RESULTS:PPⅠ sensitized TRAIL-induced decrease of viability,migration and invasion,as well as increase of apoptosis and cell cycle arrest of MG-63 and U-2 OS osteosarcoma cells.The synergistic effect of PPⅠwith TRAIL in inhibiting the growth of osteosarcoma cells was at least partially realized through the inactivation of Wnt/β-catenin signaling pathway.CONCLUSION:The combination of PPⅠ and TRAIL is potentially a novel treatment strategy of osteosarcoma.展开更多
Five to ten serotyqe I Marek’s disease virus (MDV1) strains of different pathotypes were compared for their DNA sequences of gI, gE, pp38 and meq genes. The reference strains were vMDV GA and JM, vvMDV RB1B and Md11(...Five to ten serotyqe I Marek’s disease virus (MDV1) strains of different pathotypes were compared for their DNA sequences of gI, gE, pp38 and meq genes. The reference strains were vMDV GA and JM, vvMDV RB1B and Md11(p16), vv+MDV strains 648A and 584A,vaccine strain CVI988/Rispens; Chinese strains were: v MDV strain N, vvMDV strain G2, vaccine strain 814. Only random aa changes were found in 12 positions within gE of 497 aa among 10 analyzed strains and in 10 positions within gI of 355 aa among 5 strains. There was no relationship found between virus pathotypes and aa changes of both glycoproteins. The aa changes happened in 14 positions within meq of 339 aa among 5 compared strains. But a proline deletion at aa #194 in a proline-rich domain of meq were shared by two vaccine strains CVI988/Rispens and 814, the latter was a non-pathogenic vaccine strain of serotype 1 isolated in 1983 in China. In another hand, vv+MDV strains 648A demonstrated 5 unique aa changes and 4 of them also located in the proline-rich region. The pp38 was very conservative among sequenced 10 strains, there were only two positions at #107 and #109 with aa altered in its 290 aa. All tested MDV1 strains had glutamine at #107, instead, only vaccine CVI988 had arginine at the position and lost its epitope reactive with Mab H19, to which all other tested MDV1 strains were positive. However, CVI988 and vMDV GA shared a Mab T65-recognized epitope when there was glycine at aa#109. It was glutamic acid at aa#109 in all other MDV1 strains which were not reactive with Mab T65. It seems like that there is some relationship between pathotypes and sequences of pp38 and meq, but more strains need to be compared.展开更多
基金The project supported by National Natural Science Foundation of China(81402970,81402202,81402013,81202869)
文摘OBJECTIVE To elucidate the molecular mechanism and the anti-breast cancer effect of polyphyllinⅠ,which is a natural compound extracted from Rhizoma of Paris polyphyllin.METHODS Human breast cancer cells were treated with polyphyllinⅠ,after which DRP1-dependent mitochondrial fission and apoptosis,mitophagy and PINK1/PARK2 pathway were evaluated.A genetic approach was employed to determine how knockdown of PINK1 with sh RNA regulates polyphyllinⅠ-induced mitophagy and apoptosis.The inhibitory effect of polyphyllinⅠon tumor growth in a breast cancer cell xenograft mouse model was also examined.RESULTS PolyphyllinⅠenhanced the stabilization of full-length PINK1at the mitochondrial surface,leading to PARK2 recruitment to mitochondria,and culminating in mitophagy.PolyphyllinⅠalso induced dephosphorylation of DRP1 at Ser637 and mitochondrial translocation of DRP1,leading to mitochondrial fission and apoptosis.Knockdown of PINK1 evidently suppressed mitophagy stimulated by polyphyllinⅠ,and markedly enhanced DRP1-dependent mitochondrial fission and apoptosis induced by polyphyl inⅠ.Furthermore,suppression of DRP1 by mdivi-1 or sh RNA inhibits PINK1 knockdown-mediated mitochondrial fragmentation and apoptosis in response to polyphyllinⅠtreatment,suggesting that depletion of PINK1 lead to mitochondrial fragmentation due to excessive fission.Our in vivo study also showed that knockdown of PINK1potentiated polyphyllinⅠ-mediated inhibition of tumor growth in a breast cancer cell xenograft mouse model.CONCLUSION Our study provides a mechanism to support the role of PINK1 in the regulation of polyphyl inⅠ-induced mitophagy and apoptosis,and suggest polyphylinⅠas a potential drug for treatment of breast cancer.
文摘目的:研究重楼皂苷Ⅰ(PPⅠ)对去势抵抗性人前列腺癌PC3细胞生长的抑制作用及其分子机制。方法:体外培养PC3细胞,予不同浓度(0.4、0.8、1.2、1.6、2.0、2.4μmol/L)的PPⅠ处理24、48、72 h,另设对照组,MTT法观察PPⅠ对PC3细胞增殖的影响;流式细胞术检测细胞凋亡率;Western印迹检测PPⅠ对磷酸化细胞外调节蛋白激酶1/2(p-ERK1/2)、细胞外调节蛋白激酶1/2(ERK1/2)、核转录因子kappa B(NF-κB)/p65以及DNA甲基转移酶1(DNMT1)蛋白表达的影响,并加入ERK1/2抑制剂(PD98059)后检测PPⅠ对NF-κB/p65表达的影响。结果:MTT结果显示,PPⅠ能抑制PC3细胞的体外增殖,与对照组相比,PC3细胞从给药浓度0.4μmol/L(0.85±0.05 vs 1.00±0.00,P<0.01)开始明显下降,且呈时间和剂量依赖性。流式细胞术检测显示,PPⅠ能明显诱导PC3细胞早期凋亡,与对照组相比,PC3细胞早期凋亡率从给药浓度0.8μmol/L(13.83±2.97 vs 4.83±0.95)开始明显增加(P均<0.01),且呈剂量依赖性;Western印迹显示,PPⅠ以时间依赖性上调p-ERK1/2和ERK1/2蛋白的激活与表达,与对照组相比,给药时间从2 h(1.73±0.17 vs 1.00±0.00,P<0.01)开始,p-ERK1/2明显被激活表达,PPⅠ以剂量依赖性下调NF-κB/p65、DNMT1蛋白的表达,与对照组相比,给药浓度分别从1.6μmol/L(0.67±0.11 vs 1.00,P<0.01)与1.2μmol/L(0.63±0.06 vs 1.00±0.00,P<0.01)开始,NF-κB/p65、DNMT1表达明显下调;抑制ERK1/2磷酸化能逆转重楼皂苷Ⅰ对NF-κB/p65蛋白表达的下调,与PPⅠ组相比,PD98059+PPⅠ组NF-κB/p65蛋白表达(0.86±0.18 vs 0.43±0.09,P<0.05)明显上调。结论:PPⅠ可能通过介导ERK1/2通路抑制NF-κB/p65和DNMT1蛋白表达,诱导PC3细胞早期凋亡,进而抑制细胞增殖。
基金National Key R&D Program of China:Cooperating Studies on Measurement Technologies of Human Phenome and Crossscale Correlation of Phenotypic Data(No.2020YFE0201600)National Nature Science Foundation:Study on LncRNA-CCDC18-AS1 Mediated Osteosarcoma Occurrence by Activating YAP/TAZ and Tumor Microenvironment M2 TAM-dependent Lung Metastasis,and Efficacy/mechanism of Removing Blood Stasis/clearing heat/eliminating Toxic Material Principle(No.81973877)+2 种基金Mechanism Study on m6A Methyltransferase RBM15 Mediated YAP Epigenetic Modification to Promote Osteosarcoma Lung Metastasis through Lymphatic System and Management with Qichong Powder(No.82174408)Shanghai Collaborative Innovation Center of Industrial Transformation of Hospital TCM Preparation:Preclinical Study on the Treatment of Osteosarcoma with Qingre Jiedu GranulesResearch Projects within Budget of Shanghai University of Traditional Chinese Medicine:the Research on the Mechanism of the HIPK3 Activation of Wnt/β-catenin Induction the Osteosarcoma and the Intervention of Banmao Decoction(No.2021LK047)。
文摘OBJECTIVE:To investigate the synergistic effects of polyphyllin Ⅰ(PPⅠ)combined with tumor necrosis factorrelated apoptosis-inducing ligand(TRAIL)on the growth of osteosarcoma cells through downregulating the Wnt/β-catenin signaling pathway.METHODS:Cell viability,apoptosis and cell cycle distribution were examined using cell counting kit-8 and flow cytometry assays.The morphology of cancer cells was observed with inverted phase contrast microscope.The migration and invasion abilities were examined by xCELLigence real time cell analysis DP system and transwell assays.The expressions of poly(adenosine diphosphate-ribose)polymerase,C-Myc,Cyclin B1,cyclin-dependent kinases 1,N-cadherin,Vimentin,Active-β-catenin,β-catenin,p-glycogen synthase kinase 3β(GSK-3β)and GSK-3βwere determined by Western blotting assay.RESULTS:PPⅠ sensitized TRAIL-induced decrease of viability,migration and invasion,as well as increase of apoptosis and cell cycle arrest of MG-63 and U-2 OS osteosarcoma cells.The synergistic effect of PPⅠwith TRAIL in inhibiting the growth of osteosarcoma cells was at least partially realized through the inactivation of Wnt/β-catenin signaling pathway.CONCLUSION:The combination of PPⅠ and TRAIL is potentially a novel treatment strategy of osteosarcoma.
文摘Five to ten serotyqe I Marek’s disease virus (MDV1) strains of different pathotypes were compared for their DNA sequences of gI, gE, pp38 and meq genes. The reference strains were vMDV GA and JM, vvMDV RB1B and Md11(p16), vv+MDV strains 648A and 584A,vaccine strain CVI988/Rispens; Chinese strains were: v MDV strain N, vvMDV strain G2, vaccine strain 814. Only random aa changes were found in 12 positions within gE of 497 aa among 10 analyzed strains and in 10 positions within gI of 355 aa among 5 strains. There was no relationship found between virus pathotypes and aa changes of both glycoproteins. The aa changes happened in 14 positions within meq of 339 aa among 5 compared strains. But a proline deletion at aa #194 in a proline-rich domain of meq were shared by two vaccine strains CVI988/Rispens and 814, the latter was a non-pathogenic vaccine strain of serotype 1 isolated in 1983 in China. In another hand, vv+MDV strains 648A demonstrated 5 unique aa changes and 4 of them also located in the proline-rich region. The pp38 was very conservative among sequenced 10 strains, there were only two positions at #107 and #109 with aa altered in its 290 aa. All tested MDV1 strains had glutamine at #107, instead, only vaccine CVI988 had arginine at the position and lost its epitope reactive with Mab H19, to which all other tested MDV1 strains were positive. However, CVI988 and vMDV GA shared a Mab T65-recognized epitope when there was glycine at aa#109. It was glutamic acid at aa#109 in all other MDV1 strains which were not reactive with Mab T65. It seems like that there is some relationship between pathotypes and sequences of pp38 and meq, but more strains need to be compared.
